Reviva pharmaceuticals to present at upcoming investor conferences in may 2023

Cupertino, calif., may 18, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), respiratory and metabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will be presenting at two upcoming investor conferences to be held in may 2023.
RVPH Ratings Summary
RVPH Quant Ranking